Morgan Stanley Calls Merck (MRK) a 'Catalyst Driven Idea' Ahead of March 6 Conference

Form 4 Merck & Co., Inc. For: Feb 09 Filed by: MIZELL STEVEN

February 10, 2023 11:29 AM EST

.FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color: green; background-color: white; font-size: 10px; font-family: Times, serif; } .FormNumText { font-size: 12px; font-weight: bold; font-family: arial, helvetica, sans-serif; } .FormAttention { font-size: 12px; font-weight: bold; font-family: helvetica; } .FormText { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left; } .FormTextR { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right; } .FormTextC { font-size: 12px; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center; } .FormEMText { font-size: 12px; font-style: italic; font-weight: normal;... More

Form SC 13G/A Merck & Co., Inc. Filed by: VANGUARD GROUP INC

February 9, 2023 11:01 AM EST

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934
(Amendment No.: 8)*

Name of issuer:  Merck & Co. Inc.

Title of Class of Securities:  Common Stock

CUSIP Number:  58933Y105

Date of Event Which Requires Filing of this Statement: December 30, 2022

Check the appropriate box to designate the rule pursuant to which this... More